In 2020, telehealth became a vital lifeline for both providers and patients. In this post, we recap the recent statement by HHS-OIG and offer a few tips for ensuring your telehealth services uphold program integrity and protect patients.
As we look back on an incredibly tumultuous year in healthcare, let’s explore some of the most significant healthcare fraud cases in 2020. In this post, we discuss some of the most notable cases from the OIG and DOJ.
Join ProviderTrust as we host a deep dive into all federal and state Medicaid exclusion sources, exposing the gaps and vulnerabilities in each source that leave your organization open to risk in 2021.
Everything you need to know about exclusion monitoring and the OIG LEIE, from reporting delays to false-negatives.
October HHS OIG Work Plan updates include oversight of state MFCUs, a review of national drug control program funds, an audit of COVID-19 Uninsured Program and more.
We love helping our customers improve their overall healthcare compliance program. Take a look at how we enhanced this organization’s ongoing monitoring of referral networks with NPI validation.
September HHS OIG Work Plan updates include COVID-19 data and guidance, MAO provider identifier suggestions, FDA reviews, and more.
In this guide, we’ll review healthcare exclusion authorities as they relate to rules and requirements for participation in federal healthcare programs.
Learn the best practices for exclusion and preclusion monitoring for pharmacies and prescribers.
August HHS OIG Work Plan updates include MAO risk assessments, reports on nursing home safety and emergency preparedness, COVID-19 CARES Act funding audits, and more.